We are live on ! Find out more
NSEDCP

NJ State Employees Deferred Compensation Plan Portfolio holdings

AUM $906M
1-Year Est. Return 24.85%
This Fund
S&P 500
This Quarter Est. Return
+10.32%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$618M
AUM Growth
+$34.4M
Cap. Flow
-$12M
Cap. Flow %
-1.95%
Top 10 Hldgs %
23.3%
Holding
492
New
15
Increased
–
Reduced
14
Closed
9

Top Buys

Rank Stock Value
1
APLS
Apellis Pharmaceuticals
APLS
+$318K
2
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$259K
3
MAN icon
ManpowerGroup
MAN
+$241K
4
UHS icon
Universal Health Services
UHS
+$236K
5
IR icon
Ingersoll Rand
IR
+$225K

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$3.1M
2
CTXS
Citrix Systems Inc
CTXS
+$2.08M
3
KLAC icon
KLA
KLAC
+$1.36M
4
ORCL icon
Oracle
ORCL
+$912K
5
ITW icon
Illinois Tool Works
ITW
+$745K

Sector Composition

Rank Sector Weight
1 Technology 23.28%
2 Healthcare 15.2%
3 Financials 13.94%
4 Industrials 12.19%
5 Consumer Discretionary 7.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LFUS icon
276
Littelfuse
LFUS
$11.7B
$462K 0.07%
2,100
– –
LCII icon
277
LCI Industries
LCII
$2.61B
$462K 0.07%
5,000
– –
HAYN
278
DELISTED
Haynes International, Inc.
HAYN
$457K 0.07%
10,000
– –
FIBK icon
279
First Interstate BancSystem
FIBK
$3.63B
$456K 0.07%
11,795
– –
HOMB icon
280
Home BancShares
HOMB
$6.26B
$456K 0.07%
20,000
– –
PHM icon
281
Pultegroup
PHM
$25.3B
$455K 0.07%
10,000
– –
DSKE
282
DELISTED
Daseke, Inc. Common Stock
DSKE
$455K 0.07%
80,000
– –
WNC icon
283
Wabash National
WNC
$518M
$452K 0.07%
20,000
– –
TA
284
DELISTED
TravelCenters of America LLC
TA
$448K 0.07%
10,000
– –
CRUS icon
285
Cirrus Logic
CRUS
$6.53B
$447K 0.07%
6,000
– –
NTRS icon
286
Northern Trust
NTRS
$33.7B
$442K 0.07%
5,000
– –
CUTR
287
DELISTED
Cutera, Inc.
CUTR
$442K 0.07%
10,000
– –
EXC icon
288
Exelon
EXC
$47.1B
$441K 0.07%
10,200
– –
RXDX
289
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$440K 0.07%
+4,000
New +$259K
PBH icon
290
Prestige Consumer Healthcare
PBH
$2.51B
$438K 0.07%
7,000
– –
SXT icon
291
Sensient Technologies
SXT
$5.54B
$438K 0.07%
6,000
– –
HAIN icon
292
Hain Celestial
HAIN
$50.3M
$437K 0.07%
27,000
– –
BWXT icon
293
BWX Technologies
BWXT
$15.4B
$436K 0.07%
7,500
– –
HSKA
294
DELISTED
Heska Corp
HSKA
$435K 0.07%
7,000
– –
NOG icon
295
Northern Oil and Gas
NOG
$2.22B
$431K 0.07%
14,000
– –
FLEX icon
296
Flex
FLEX
$45B
$429K 0.07%
26,540
– –
RJF icon
297
Raymond James Financial
RJF
$34.7B
$427K 0.07%
4,000
– –
ARWR icon
298
Arrowhead Research
ARWR
$12.3B
$426K 0.07%
10,500
– –
MGPI icon
299
MGP Ingredients
MGPI
$379M
$426K 0.07%
4,000
– –
MTX icon
300
Minerals Technologies
MTX
$2.4B
$425K 0.07%
7,000
– –
10 11
12
13 14

Similar funds

IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BFS
Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
CP
Coho Partners Berwyn, Pennsylvania $779M AUM 4.46% 1-Year Est. Return
EAM
EFG Asset Management Portland, Oregon $773M AUM 40.1% 1-Year Est. Return
HWM
Hemington Wealth Management Falls Church, Virginia $769M AUM 13.16% 1-Year Est. Return
BVDMP
Bedrijfstakpensioenfonds Voor De Media PNO Hilversum, Netherlands $759M AUM 19.37% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's Q4 2022 Portfolio in Review

As of Q4 2022, NJ State Employees Deferred Compensation Plan held 492 positions worth $618M, up 5.9% from $584M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q4 2022: portfolio turnover was 4.9%. NJ State Employees Deferred Compensation Plan opened 15 new positions and exited 9, leaving the 492-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • NJ State Employees Deferred Compensation Plan's largest Q4 2022 buy was Apellis Pharmaceuticals: 6,000 shares worth $310K.
  • NJ State Employees Deferred Compensation Plan's biggest Q4 2022 reduction was KLA, cutting an estimated $1.36M.
  • NJ State Employees Deferred Compensation Plan fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $3.1M.
  • NJ State Employees Deferred Compensation Plan's ten largest holdings make up 23% of its $618M portfolio in Q4 2022.
  • NJ State Employees Deferred Compensation Plan opened 15 new positions and closed 9 in Q4 2022.
  • NJ State Employees Deferred Compensation Plan's portfolio value rose 5.9% quarter-over-quarter to $618M.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2022, filed 26 Jan 2023.